Literature DB >> 7354140

Influence of passage familiarity on intelligibility estimates of dysarthric speech.

D R Beukelman, K M Yorkston.   

Abstract

Speech pathologists often estimate intelligibility as dysarthric speakers read standard passages. The first phase of this study compared estimates of intelligibility made by speech pathologists with transcription scores made by judges unfamiliar with the speech passages. Results indicated that speech pathologists consistently overestimated intelligibility. It was hypothesized that judge familiarity with the speech sample contributed to these inflated scores. Therefore, during the second phase of the study the influence of speech sample familiarity on estimates of intelligiblity was investigated. Group of listeners judged mild, moderate, and severely dysarthric speakers under three conditions of familiarity--Unfamiliar (passage unknown), Partially Familiar (passage read twice by a normal speaker), and Most Familiar (script of the passage available). For mild and severely dysarthric speakers, passage familiarity did not significantly influence judges' estimates. For the moderately dysarthric speaker, estimates of intelligibility increased markedly with increasing passage familiarity. Clinical implications of these results are discussed.

Entities:  

Mesh:

Year:  1980        PMID: 7354140     DOI: 10.1016/0021-9924(80)90019-2

Source DB:  PubMed          Journal:  J Commun Disord        ISSN: 0021-9924            Impact factor:   2.288


  2 in total

1.  Visual Analog Scale Ratings and Orthographic Transcription Measures of Sentence Intelligibility in Parkinson's Disease With Variable Listener Exposure.

Authors:  Defne Abur; Nicole M Enos; Cara E Stepp
Journal:  Am J Speech Lang Pathol       Date:  2019-07-11       Impact factor: 2.408

2.  Intelligibility Across a Reading Passage: The Effect of Dysarthria and Cued Speaking Styles.

Authors:  Frits van Brenk; Kaila Stipancic; Alexander Kain; Kris Tjaden
Journal:  Am J Speech Lang Pathol       Date:  2022-01-04       Impact factor: 4.018

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.